1. Castracane VD, Stewart DR, Gimpel T, Overstreet JW, Lasley BL. Maternal serum androgens in human pregnancy: early increases within the cycle of conception. Hum Reprod. 1998;13(2):460–4. [PubMed] [Google Scholar]
2. Nacht S, Yeung D, Beasley JN, Jr, Anjo MD, Maibach HI. Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981;4(1):31–7. [PubMed] [Google Scholar]
3. Morsches B, Holzmann H. Studies on the percutaneous absorption of benzoyl peroxide (author’s transl) [article in German] Arzneimittelforschung. 1982;32(3):298–300. [PubMed] [Google Scholar]
4. Van Hoogdalem EJ. Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol. 1998;11(Suppl 1):S13–9. [PubMed] [Google Scholar]
5. Van Hoogdalem EJ, Baven TL, Spiegel-Melsen I, Terpstra IJ. Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man. Biopharm Drug Dispos. 1998;19(9):563–9. [PubMed] [Google Scholar]
6. Schmidt JB, Knobler R, Neumann R, Poitschek C. External erythromycin therapy of acne [article in German] Z Hautkr. 1983;58(24):1754–60. [PubMed] [Google Scholar]
7. Cosmetic Ingredient Review Expert Panel Safety assessment of salicylic acid, butyloctyl salicylate, calcium salicylate, C12-15 alkyl salicylate, capryloyl salicylic acid, hexyldodecyl salicylate, isocetyl salicylate, isodecyl salicylate, magnesium salicylate, MEA-salicylate, ethylhexyl salicylate, potassium salicylate, methyl salicylate, myristyl salicylate, sodium salicylate, TEA-salicylate, and tridecyl salicylate. Int J Toxicol. 2003;22(Suppl 3):1–108. [PubMed] [Google Scholar]
8. Kraeling MK, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cosmet Chem. 1997;48:187–97. [Google Scholar]
9. Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, et al. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition. J Toxicol Environ Health A. 1998;54(4):301–17. [PubMed] [Google Scholar]
10. Sarveiya V, Risk S, Benson HA. Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;803(2):225–31. [PubMed] [Google Scholar]
11. Gonzalez H, Farbrot A, Larkö O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol. 2006;154(2):337–40. [PubMed] [Google Scholar]
12. Yourick JJ, Koenig ML, Yourick DL, Bronaugh RL. Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption? Toxicol Appl Pharmacol. 2004;195(3):309–20. [PubMed] [Google Scholar]
13. Guy RH, Hosynek JJ, Hinz RS, Lorence CR. Metals and the skin. Topical effects and systemic absorption. New York, NY: Informa Health Care; 1999. [Google Scholar]
14. European Commission, Directorate-General Joint Research Centre, Institute of Health and Consumer Protection, European Chemicals Bureau . European Union risk assessment report. Hydrogen peroxide. Luxembourg, Belgium: Office for Official Publications of the European Communities; 2003. Available from: //ecb.jrc.ec.europa.eu/documents/Existing-Chemicals/RISK_ASSESSMENT/REPORT/hydrogenperoxidereport022.pdf. Accessed 2011 Apr 27. [Google Scholar]
15. Lipson AH, Collins F, Webster WS. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet. 1993;341(8856):1352–3. [PubMed] [Google Scholar]
16. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993;341(8854):1181–2. [PubMed] [Google Scholar]
17. Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, Sarda P, Blayac J-P. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother. 1998;32(4):505–6. [PubMed] [Google Scholar]
18. Selcen D, Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev. 2000;22(4):218–20. [PubMed] [Google Scholar]
19. Shapiro L, Pastuszak A, Curto G, Koren G. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet. 1997;350(9085):1143–4. [PubMed] [Google Scholar]
20. Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, et al. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136(2):117–21. [PubMed] [Google Scholar]
21. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. p. 384. [Google Scholar]
22. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003;361(9362):983–8. [PubMed] [Google Scholar]
23. McCormack WM, Rosner B, Lee YH, Munoz A, Charles D, Kass EH. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol. 1987;69(2):202–7. [PubMed] [Google Scholar]
24. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group; 1977. pp. 297–313. [Google Scholar]
25. Rothman KF, Pochi PE. Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol. 1988;19(3):431–42. [PubMed] [Google Scholar]
26. James AH, Brancazio LR, Price T. Aspirin and reproductive outcomes. Obstet Gynecol Surv. 2008;63(1):49–57. [PubMed] [Google Scholar]
27. Munley SM, Kennedy GL, Hurtt ME. Developmental toxicity study of glycolic acid in rats. Drug Chem Toxicol. 1999;22(4):569–82. [PubMed] [Google Scholar]
28. Andersen FA. Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and TEA-lactates, methyl, ethyl, isopropyl, and butyl lactates, and lauryl, myristyl, and cetyl lactates. Int J Toxicol. 1998;17(Suppl 1):1–241. [Google Scholar]
29. Mahé A, Perret JL, Ly F, Fall F, Rault JP, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg. 2007;101(2):183–7. Epub 2006 Oct 4. [PubMed] [Google Scholar]
30. Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40(7):455–8. [PubMed] [Google Scholar]
31. Health Canada . List of prohibited and restricted cosmetic ingredients (the cosmetic ingredient “hotlist”) Ottawa, ON: Health Canada; 2007. Available from: www.hc-sc.gc.ca/cps-spc/person/cosmet/info-ind-prof/_hot-list-critique/hotlist-liste_3-eng.php. Accessed 2009 Feb 2. [Google Scholar]
32. European Commission, Directorate-General Joint Research Centre, Institute of Health and Consumer Protection, European Chemicals Bureau . European Union risk assessment report. Sodium hydroxide. Luxembourg, Belgium: Office for Official Publications of the European Communities; 2007. Available from: //ecb.jrc.ec.europa.eu/documents/Existing-Chemicals/RISK_ASSESSMENT/REPORT/sodiumhydroxidereport416.pdf. Accessed 2011 Apr 27. [Google Scholar]
Page 2
Absorption of products following topical use
| Benzoyl peroxide | Not detected in serum. Small amounts of the metabolite benzoate are absorbed and easily eliminated2,3 |
| Tretinoin | Endogenous vitamin A levels remained unchanged after repeated applications of 0.05% tretinoin4 |
| Clindamycin phosphate | Not detected in plasma5 |
| Erythromycin | Not detectable in serum6 |
| Salicylic acid | Undetectable from up to 25% in normal skin (depends on vehicle, pH, strength, and quantity applied). Levels might be higher when applied to damaged skin7 |
| Glycolic acid | Up to 27% is absorbed into the skin, dependent on pH, concentration, and time8 |
| Hydroquinone | 35%–45.3% is systemically absorbed through the skin9 |
| Sunscreens (oxybenzone, octocrylene, octisalate) | Below the limit of detection up to 8.7%10,11 |
| Dihydroxyacetone (self-tanning) | Estimated at 0.5% systemically available12 |
| Depilatory products | |
| • Thioglycolic acid | Human studies on systemic absorption of thioglycolic acid have not been conducted |
| • Sodium, calcium, and potassium hydroxide | The amount found in consumer products, which would come in contact with skin, would be negligible compared with daily dietary intakes of these ions and therefore would not increase serum levels13 |
| Hydrogen peroxide (skin bleaching) | In an in vitro study involving human skin, hydrogen peroxide was detectable in the dermis only after the application of high hydrogen peroxide concentrations for several hours14 |